ArticleAmerican journal of ophthalmology case reports2025
Atypical orbital mass as the precursor for myelodysplastic syndrome recurrence: a case report.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Myelodysplastic syndrome (MDS) has the potential to progress into acute myeloid leukemia (AML), even in patients in remission. Granulocytic sarcomas are extramedullary manifestations of AML that can rarely occur in the orbit and in the absence of systemic signs of disease. We describe the unusual presentation of an isolated orbital mass in an adult patient at high-risk for development of AML. Observations: A 42-year-old male with a history of MDS in remission for nearly two years after chemotherapy and bone marrow transplant presented with unilateral eye pain and swelling, blurry vision, diplopia, and dizziness. Imaging revealed a unilateral intraconal extraocular mass, and laboratory workup at that time was negative for signs of systemic disease. Multiple biopsies showed no pathologic or immunohistochemical signs of malignancy. A bone marrow biopsy ultimately revealed MDS recurrence with AML. Conclusions and Importance: This case highlights the unusual manifestation of AML as a unilateral extraocular mass and the importance of clinical correlation with negative pathological studies. It is crucial to accurately establish a diagnosis of AML to improve patient outcomes, especially in high-risk cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.